glycyl-arginyl-glycyl-aspartyl-seryl-proline has been researched along with Adenocarcinoma in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Casey, RC; Grindle, SM; Koch, KA; Oegema, TR; Pambuccian, SE; Skubitz, AP; Skubitz, KM | 1 |
1 other study(ies) available for glycyl-arginyl-glycyl-aspartyl-seryl-proline and Adenocarcinoma
Article | Year |
---|---|
Establishment of an in vitro assay to measure the invasion of ovarian carcinoma cells through mesothelial cell monolayers.
Topics: Adenocarcinoma; Antibodies, Blocking; Antibodies, Monoclonal; Antigens, Neoplasm; Coculture Techniques; Dipeptides; Disintegrins; Epithelium; Female; Humans; Integrin beta1; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Matrix Metalloproteinases; Neoplasm Invasiveness; Oligopeptides; Ovarian Neoplasms; Protease Inhibitors; Tissue Inhibitor of Metalloproteinases; Tumor Cells, Cultured | 2003 |